indapamide has been researched along with Body Weight in 29 studies
Indapamide: A benzamide-sulfonamide-indole derived DIURETIC that functions by inhibiting SODIUM CHLORIDE SYMPORTERS.
indapamide : A sulfonamide formed by condensation of the carboxylic group of 4-chloro-3-sulfamoylbenzoic acid with the amino group of 2-methyl-2,3-dihydro-1H-indol-1-amine.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 9.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "The long-term effects of indapamide or hydrochlorothiazide on blood pressure and renal function were examined in patients with impaired renal function and moderate hypertension." | 9.08 | Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. ( Gadallah, M; Madkour, H; Massry, SG; Plante, GE; Riveline, B, 1995) |
| "A multicenter, double-blind, parallel-group study of 219 patients with pitting edema of various causes was undertaken to determine the efficacy and safety of indapamide, administered orally (PO) in a 2." | 9.05 | Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema. ( Bratnick, J; Eff, J; Neiss, E; Vukovich, RA; Zisblatt, M, 1984) |
| "1 To compare the efficacy of indapamide with that of bendrofluazide a randomised trial was carried out in twenty patients with essential hypertension." | 9.05 | Indapamide and bendrofluazide: a comparison in the management of essential hypertension. ( Bing, RF; Russell, GI; Swales, JD; Thurston, H, 1981) |
| "A controlled multicentre trial was organised to compare the effects of 20 mg Nifedipine tablets (N) and 2,5 mg Indapamide tablets (I) during a 4 months' treatment period after a placebo period, in 59 patients with moderate essential hypertension (n = 59)." | 9.05 | [Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension]. ( Aubert, P; Chaignon, M; Guédon, J; Lucsko, M; Rapoud, JP, 1985) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 7.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| "To compare efficacy and safety of indapamide-furosemide combination against metolazone-furosemide combination in refractory heart failure patients." | 5.30 | Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial. ( Altaf, A; Jan, MU; Salahudin, M; Shah, H, 2019) |
| "Indapamide was given in doses of 2." | 5.27 | Clinical efficacy and safety of indapamide in the treatment of edema. ( Slotkoff, L, 1983) |
| "The long-term effects of indapamide or hydrochlorothiazide on blood pressure and renal function were examined in patients with impaired renal function and moderate hypertension." | 5.08 | Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension. ( Gadallah, M; Madkour, H; Massry, SG; Plante, GE; Riveline, B, 1995) |
| "A multicenter, double-blind, parallel-group study of 219 patients with pitting edema of various causes was undertaken to determine the efficacy and safety of indapamide, administered orally (PO) in a 2." | 5.05 | Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema. ( Bratnick, J; Eff, J; Neiss, E; Vukovich, RA; Zisblatt, M, 1984) |
| "1 To compare the efficacy of indapamide with that of bendrofluazide a randomised trial was carried out in twenty patients with essential hypertension." | 5.05 | Indapamide and bendrofluazide: a comparison in the management of essential hypertension. ( Bing, RF; Russell, GI; Swales, JD; Thurston, H, 1981) |
| "A controlled multicentre trial was organised to compare the effects of 20 mg Nifedipine tablets (N) and 2,5 mg Indapamide tablets (I) during a 4 months' treatment period after a placebo period, in 59 patients with moderate essential hypertension (n = 59)." | 5.05 | [Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension]. ( Aubert, P; Chaignon, M; Guédon, J; Lucsko, M; Rapoud, JP, 1985) |
| "The results of a study conducted using a new loop diuretic, Azosemide, on a group of 45 patients suffering from hypertension and oedema are reported." | 3.67 | [Diuretic and antihypertensive activity of azosemide]. ( Bartoli, E; Branca, GF; Faedda, R; Satta, A, 1985) |
| "The onset of DOCA-salt hypertension in male Sprague-Dawley rats was prevented during 11 weeks of oral treatment with indapamide (0." | 3.66 | The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies. ( Hicks, PE, 1979) |
| " The results obtained from single-blind, placebo-controlled studies indicate that indapamide is a safe and effective agent to use in lowering the blood pressure of hypertensive patients with normal renal function, those with various degrees of renal impairment, and those who are undergoing long-term maintenance hemodialysis." | 2.65 | Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment. ( Acchiardo, SR; Skoutakis, VA, 1983) |
| " Dose-response relationships to these pressor agents were shifted in parallel to the right after treatment." | 2.65 | Extrarenal contributions to indapamide's antihypertensive mechanism of action. ( Giles, T; McMahon, FG; Noveck, RJ; Quiros, A, 1983) |
| "Hydrochlorothiazide treatment was associated with hypokalemia, which was not present in losartan or indapamide treatment." | 1.36 | Comparative study of hydrochlorothiazide and indapamide on the anti-atherogenic potential of losartan in cholesterol fed rat. ( Islam, MZ; Rahman, MS, 2010) |
| "5 mg/kg/day) combined with indapamide (0." | 1.31 | Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis. ( Agnati, LF; Biagini, G; Boschi, S; Torri, C; Vantaggiato, G; Zini, I; Zoli, M, 2000) |
| "Indapamide was given in doses of 2." | 1.27 | Clinical efficacy and safety of indapamide in the treatment of edema. ( Slotkoff, L, 1983) |
| "Renal hypertrophy was also decreased significantly by cicletanine at a dose of 100 mg/kg." | 1.27 | Comparison of cicletanine with other antihypertensive drugs in SHR-SP models. ( Braquet, P; Clostre, F; Le Hegarat, M; Malherbe, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (58.62) | 18.7374 |
| 1990's | 8 (27.59) | 18.2507 |
| 2000's | 2 (6.90) | 29.6817 |
| 2010's | 2 (6.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salahudin, M | 1 |
| Shah, H | 1 |
| Jan, MU | 1 |
| Altaf, A | 1 |
| Islam, MZ | 1 |
| Rahman, MS | 1 |
| Sládková, M | 1 |
| Kojsová, S | 1 |
| Jendeková, L | 1 |
| Pechánová, O | 1 |
| Acchiardo, SR | 1 |
| Skoutakis, VA | 1 |
| Leenen, FH | 1 |
| Smith, DL | 1 |
| Boer, WH | 1 |
| Marquez-Julio, A | 1 |
| Campbell, DB | 1 |
| Eff, J | 1 |
| Bratnick, J | 1 |
| Zisblatt, M | 1 |
| Vukovich, RA | 1 |
| Neiss, E | 1 |
| Noveck, RJ | 1 |
| McMahon, FG | 1 |
| Quiros, A | 1 |
| Giles, T | 1 |
| Slotkoff, L | 1 |
| Bing, RF | 1 |
| Russell, GI | 1 |
| Swales, JD | 1 |
| Thurston, H | 1 |
| Weidmann, P | 1 |
| Grimm, M | 1 |
| Meier, A | 1 |
| Keusch, G | 1 |
| Ziegler, W | 1 |
| Glück, Z | 1 |
| Beretta-Piccoli, C | 1 |
| Brennan, L | 1 |
| Wu, MJ | 1 |
| Laquer, UJ | 1 |
| Anania, V | 1 |
| Bartoli, E | 2 |
| Desole, MS | 1 |
| Faedda, R | 2 |
| Miele, E | 1 |
| Olmeo, NA | 1 |
| Satta, A | 2 |
| Soggia, G | 1 |
| Vacca, R | 1 |
| Lebrillant, E | 1 |
| Roulet, MJ | 1 |
| Robert, R | 1 |
| Schiavi, P | 1 |
| Guez, D | 1 |
| Jean, T | 1 |
| Del Rio, M | 1 |
| Chulia, T | 1 |
| Merchan-Perez, A | 1 |
| Remezal, M | 1 |
| Valor, S | 1 |
| Gonzalez, J | 1 |
| Gutierrez, JA | 1 |
| Contreras, JA | 1 |
| Lasuncion, MA | 1 |
| Tejerina, T | 1 |
| Madkour, H | 1 |
| Gadallah, M | 1 |
| Riveline, B | 1 |
| Plante, GE | 1 |
| Massry, SG | 1 |
| Levy, BI | 1 |
| Poitevin, P | 1 |
| Duriez, M | 1 |
| Guez, DC | 1 |
| Schiavi, PD | 1 |
| Safar, ME | 1 |
| Biagini, G | 3 |
| Zoli, M | 2 |
| Torri, C | 2 |
| Boschi, S | 2 |
| Vantaggiato, G | 2 |
| Ballestri, M | 1 |
| Baraldi, A | 1 |
| Agnati, LF | 2 |
| Razzetti, R | 1 |
| Bongrani, S | 1 |
| Oberto, G | 1 |
| Ferrari, R | 1 |
| Wing, LM | 1 |
| Arnolda, LF | 1 |
| Harvey, PJ | 1 |
| Upton, J | 1 |
| Molloy, D | 1 |
| Gabb, GM | 1 |
| Bune, AJ | 1 |
| Chalmers, JP | 1 |
| Zini, I | 1 |
| Hicks, PE | 1 |
| Elliott, WJ | 1 |
| Weber, RR | 1 |
| Murphy, MB | 1 |
| Poulsen, L | 1 |
| Friberg, M | 1 |
| Noer, I | 1 |
| Krusell, L | 1 |
| Pedersen, OL | 1 |
| Yasujima, M | 1 |
| Abe, K | 1 |
| Kanazawa, M | 1 |
| Yoshida, K | 1 |
| Kohzuki, M | 1 |
| Sato, M | 1 |
| Takeuchi, K | 1 |
| Omata, K | 1 |
| Tsunoda, K | 1 |
| Kudo, K | 1 |
| Malherbe, E | 1 |
| Le Hegarat, M | 1 |
| Clostre, F | 1 |
| Braquet, P | 1 |
| Machová, A | 1 |
| Chaignon, M | 1 |
| Lucsko, M | 1 |
| Rapoud, JP | 1 |
| Aubert, P | 1 |
| Guédon, J | 1 |
| Branca, GF | 1 |
1 review available for indapamide and Body Weight
| Article | Year |
|---|---|
The possible mode of action of indapamide: a review.
Topics: Benzothiadiazines; Biological Transport; Blood Pressure; Body Weight; Cardiac Output; Diuresis; Diur | 1983 |
11 trials available for indapamide and Body Weight
| Article | Year |
|---|---|
Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Body Weight; Diuretics; Drug Therapy, Combi | 2019 |
Clinical efficacy, safety, and pharmacokinetics of indapamide in renal impairment.
Topics: Aldosterone; Blood Pressure; Body Weight; Diuretics; Hemodynamics; Humans; Hypertension; Indapamide; | 1983 |
Diuretic and cardiovascular effects of indapamide in hypertensive subjects: a dose-response curve.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Dose-Response Rel | 1983 |
Indapamide, a new antihypertensive/diuretic agent, in the treatment of patients with edema.
Topics: Antihypertensive Agents; Body Weight; Diuretics; Drug Evaluation; Edema; Humans; Hydrochlorothiazide | 1984 |
Extrarenal contributions to indapamide's antihypertensive mechanism of action.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Body Weight; Chemical Phenomena; Chemistry; Diuretic | 1983 |
Indapamide and bendrofluazide: a comparison in the management of essential hypertension.
Topics: Adult; Bendroflumethiazide; Blood Pressure; Body Weight; Diuretics; Electrolytes; Female; Humans; Hy | 1981 |
Comparison between the effects of indapamide and hydrochlorothiazide on creatinine clearance in patients with impaired renal function and hypertension.
Topics: Body Weight; Creatinine; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertensi | 1995 |
Low-dose diuretic and/or dietary sodium restriction when blood pressure is resistant to ACE inhibitor.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure | 1998 |
A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide.
Topics: Blood Pressure; Body Weight; Double-Blind Method; Female; Heart Rate; Humans; Hydrochlorothiazide; H | 1991 |
Comparison of indapamide and hydrochlorothiazide plus amiloride as a third drug in the treatment of arterial hypertension.
Topics: Adult; Aged; Amiloride; Blood Pressure; Body Weight; Double-Blind Method; Female; Heart Rate; Humans | 1989 |
[Comparative effects of nifedipine and indapamide in the treatment of arterial hypertension].
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Diastole; Diuretics; Heart Rate; Human | 1985 |
17 other studies available for indapamide and Body Weight
| Article | Year |
|---|---|
Comparative study of hydrochlorothiazide and indapamide on the anti-atherogenic potential of losartan in cholesterol fed rat.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Body Weight; Cholesterol, Dietary; Diuretics; Hyd | 2010 |
Chronic and acute effects of different antihypertensive drugs on femoral artery relaxation of L-NAME hypertensive rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pre | 2007 |
Clinical efficacy and safety of indapamide in the treatment of edema.
Topics: Body Weight; Diuretics; Double-Blind Method; Edema; Electrolytes; Female; Humans; Hydrochlorothiazid | 1983 |
[Studies of antihypertensional mechanism of indapamide (author's transl)].
Topics: Blood Pressure; Blood Volume; Body Weight; Diuretics; Humans; Hypertension; Indapamide | 1982 |
A multicenter study of indapamide in hypertensive patients with impaired renal function.
Topics: Adult; Aged; Blood Pressure; Body Weight; Creatinine; Diuretics; Female; Humans; Hypertension; Indap | 1982 |
[Evaluation of the combination of atenolol and indapamide in the therapy of arterial hypertension (with data concerning toxicity and tolerance in the experimental animal)].
Topics: Adult; Aged; Animals; Atenolol; Blood Pressure; Body Weight; Diuretics; Dogs; Drug Therapy, Combinat | 1981 |
Study of antiatherogenic properties of indapamide in a pharmacologic model.
Topics: Animals; Arteriosclerosis; Basement Membrane; Body Weight; Carotid Arteries; Cell Division; Choleste | 1993 |
Effects of indapamide on atherosclerosis development in cholesterol-fed rabbits.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Aorta; Arteriosclerosis; Blood Pressure; Bod | 1995 |
Sodium, survival, and the mechanical properties of the carotid artery in stroke-prone hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Carotid Artery, Common; Cerebrovascular Disorders; Collagen; D | 1997 |
Protective effects of delapril, indapamide and their combination chronically administered to stroke-prone spontaneously hypertensive rats fed a high-sodium diet.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bl | 1997 |
Protective effects of delapril, indapamide and their combination on stroke occurrence and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cerebrovascular Disorders; Diuretics | 1998 |
Protective effects of delapril combined with indapamide or hydrochlorothiazide in spontaneously hypertensive stroke-prone rats: a comparative dose-response analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Diuretics; Dose-Resp | 2000 |
The effects of long term oral treatment with indapamide on the development of DOCA-salt hypertension in rats: vascular reactivity studies.
Topics: Animals; Blood Pressure; Body Weight; Desoxycorticosterone; Diuretics; Eating; Hypertension; Indapam | 1979 |
Effects of antihypertensive drugs on renal function and atrial natriuretic polypeptide in spontaneously hypertensive rats with renal ablation.
Topics: Animals; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Calcium Ch | 1989 |
Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Cardiomegaly; Diuresis; Di | 1988 |
The diuretic effect of metipamide and its relationship to body weights in rats.
Topics: Animals; Antihypertensive Agents; Body Weight; Diuretics; Drinking; Eating; Female; Indapamide; Male | 1988 |
[Diuretic and antihypertensive activity of azosemide].
Topics: Body Weight; Diuresis; Edema; Humans; Hypertension; Indapamide; Kidney Failure, Chronic; Sulfanilami | 1985 |